Holen Sie sich die Stockscreener-App
20.18
2.89%
-0.5768
Hims Hers Health Inc Aktie (HIMS) Neueste Nachrichten
-3.88% for Hims & Hers Health stock as oscillators give mixed signals near session low - Traders Union
Hims & Hers Stock Is Down 63% Over the Past 6 Months. Here’s Why the Valuation Still Looks Compelling - TIKR.com
Novo Partnership Fuels Long-Term Optimism for Hims & Hers Health, Inc. (HIMS) - Insider Monkey
Hims & Hers Broadens Tailored Online Health Services Platform - Bitget
Slash Your Wegovy Costs: Novo Nordisk Reveals First-Ever Subscription Plan - Benzinga
Hims & Hers Health Inc (HIMS) Stock Price Up 6.42% on Mar 31 - GuruFocus
Hims & Hers Expands Personalized Digital Healthcare Platform - TradingView
HIMS Gains as FDA Revisits Rules on Compounding Pharmacies - GuruFocus
HIMS Stock Gains As FDA Reportedly Moves Toward Lifting Restrictions On Peptides - Stocktwits
Hims Novo Nordisk GLP-1 Launch Ties Growth Story To Valuation Gap - simplywall.st
Hims & Hers Health, Inc. (HIMS) registers a bigger fall than the market: Important facts to note - MSN
HIMS Sees Moderate Bearish Sentiment Among Option Traders - GuruFocus
Hims & Hers Health, Inc. (HIMS) Registers a Bigger Fall Than the Market: Important Facts to Note - Yahoo Finance Australia
Hims & Hers Health Options Spot-On: On March 30th, 88,151 Contracts Were Traded, With 1.15 Million Open Interest - Moomoo
HIMS stock in spotlight after Hims & Hers adds Novo’s GLP-1 treatments to its platform - MSN
Why (HIMS) Price Action Is Critical for Tactical Trading - Stock Traders Daily
Hims & Hers Health, Inc. (HIMS) Experiences a Sharper Decline Compared to the Overall Market: Key Points to Consider - Bitget
Hims & Hers Health stock price forecast: persistent bearish setup as HIMS extends decline toward $18 - Traders Union
SG Americas Securities LLC Boosts Stock Position in Hims & Hers Health, Inc. $HIMS - MarketBeat
Hims & Hers Health Options Spot-On: On March 27th, 145.81K Contracts Were Traded, With 1.12 Million Open Interest - Moomoo
Barclays raises PT on Hims & Hers Health (HIMS) stock - MSN
Hims & Hers Stock Decline Amid Legal Battles and Strategic Repositioning - StocksToTrade
Enovis, Neogen, Humana, LifeStance Health Group, and Hims & Hers Health Stocks Trade Down, What You Need To Know - Yahoo Finance
TD Cowen Has Lowered Expectations for Hims & Hers Health (NYSE:HIMS) Stock Price - MarketBeat
Hims & Hers Health Launches Offering Featuring Novo Nordisk Products - marketscreener.com
From Breaking Stigma to Building the Future of Health - Hims & Hers Newsroom
Hims & Hers Health | SCHEDULE 13G/A: Others - Moomoo
Hims & Hers expands integrated digital healthcare ecosystem - msn.com
Hims & Hers: The Reset Before The Next Inflection (NYSE:HIMS) - Seeking Alpha
Vanguard (HIMS) reports 0 shares after internal realignment — Schedule 13G/A - Stock Titan
Hims & Hers Health (HIMS) price target decreased by 14.58% to 25.63 - MSN
CCORF Maintains Hims & Hers Health(HIMS.US) With Buy Rating, Maintains Target Price $30 - Moomoo
Canaccord reiterates Hims and Hers stock rating on Novo launch - Investing.com
Canaccord reiterates Hims and Hers stock rating on Novo launch By Investing.com - Investing.com India
HIMS Forecast, Price Target & Analyst Ratings | HIMS & HERS HEALTH INC (NYSE:HIMS) - ChartMill
Oil Surge Past $100, S&P 500 Changes & AI Trends | Market AnalysisNews and Statistics - IndexBox
Hims & Hers shifts business model after Novo deal - thestreet.com
Hims and Hers stock price target maintained at $23 by BofA Securities - Investing.com South Africa
What's Happening With Novo Nordisk Stock Today? - Benzinga
Hims & Hers Health (HIMS) Expands Offerings with Novo Nordisk Me - GuruFocus
-3.50% for Hims & Hers Health stock as daily low tests immediate support - Traders Union
Hims & Hers Health starts selling Novo Nordisk's Wegovy, Ozempic - Seeking Alpha
Why is Hims & Hers Health stock down today? - Traders Union
Hims & Hers adds Novo Nordisk GLP-1 medications to platform - Investing.com
Novo Nordisk’s FDA-Approved GLP-1s Now Available With Hims & Hers - HIMS Investor Relations
Wegovy® Pill and Wegovy® Pen Now Available with Hims & Hers - Hims & Hers Newsroom
It’s Easier Than Ever To Get A Prescription Online. That Might Be A Problem - MedShadow Foundation
HIMS Stock In Spotlight After Hims & Hers Adds Novo’s GLP-1 Treatments To Its Platform - Stocktwits
Hims & Hers Health Options Spot-On: On March 25th, 136.26K Contracts Were Traded, With 1.06 Million Open Interest - Moomoo
Hims & Hers: Distressed Valuations Will Not Last For Long (NYSE:HIMS) - Seeking Alpha
HIMS Investors Have Opportunity to Join Hims & Hers Health, Inc. Fraud Investigation with the Schall Law Firm - GlobeNewswire
HIMS vs. DOCS: Which Digital Health Stock Offers Better Upside Now? - TradingView
With Legal Overhang Behind, Hims Looks To Drive Growth via Novo Partnership and International Push - Morningstar
Hims & Hers Health stock slips 3.33% as resistance holds and sellers dominate near $20.00 support - Traders Union
HIMS Stock | Hims & Hers Health, Inc. Price, Quote, News & Analysis - TipRanks
Oluyemi Okupe Sells 9,217 Shares of Hims & Hers Health (NYSE:HIMS) Stock - MarketBeat
Hers Review: Is It Right for You? - Healthline
Hims & Hers Faces Multifaceted Challenges as Investor Confidence Wavers - AD HOC NEWS
Okupe, Hims & Hers health CFO, sells $219k in shares - Investing.com
[Form 4] Hims & Hers Health, Inc. Insider Trading Activity - Stock Titan
Hims & Hers Health, Inc. (HIMS) Dips More Than Broader Market: What You Should Know - Yahoo Finance
Canaccord Lowers Hims & Hers Health, Inc. (HIMS) Price Target Patent Amid Dispute and FDA Scrutiny - MSN
Hims & Hers Faces Legal Scrutiny Over Wegovy Sales - StocksToTrade
Hims & Hers Health Options Spot-On: On March 24th, 116.22K Contracts Were Traded, With 1.04 Million Open Interest - Moomoo
Hims & Hers Health (HIMS) Valuation After Novo Nordisk Weight Loss Deal And Product Exit - Yahoo Finance
INSP vs. HIMS: Which Stock Should Value Investors Buy Now? - Yahoo! Finance Canada
2.14%
0.25%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):